The genetically modified animal model could lead to new treatments for the global disease Lauren Rust, Ph.D., assistant staff ...

On 12 Feb 2025, Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has ...

HBV infection is a significant biological risk for healthcare workers (HCW), as HCW are exposed to human fluids and consequently to blood-borne pathogens. Prior to the introduction of the ...

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

The firm will study its autologous cell therapy alone and in combination with Eisai's Lenvima in patients with hepatitis B-driven hepatocellular carcinoma.

A new study published in the journal of Nature Scientific Reports found that anemia was almost three times as common in women ...

Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths ...

By Dr. Liji Thomas, MD New recommendations address advances in immunosuppressive therapies and highlight antiviral prophylaxis for high-risk patients. Study: AGA Clinical Practice Guideline on the ...

The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...

Proceeds expected to fund the start of the ALG-000184 Phase 2 clinical studyFunding expected to extend cash runway into the second half of ...